These observations suggest that one plausible explanation for the conflicting data on the effects of DPP4is on BP is that their ability to enhance pS552‐NHE3 levels and inhibit NHE3 activity is already maximized in established hypertension, rendering further intervention ineffective. This evidence concerns the gene SLC9A3 and hypertensive disorder.